What is LOPJLB’s current signal on CNSY?

LOPJLB’s latest quantitative signal on Cerenome, Inc. (CNSY) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is CNSY in?

Cerenome, Inc. (CNSY) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Cerenome, Inc. (CNSY) do?

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Where is Cerenome, Inc. based / listed?

Cerenome, Inc. is based in US, listed on NASDAQ.

Cerenome, Inc. (CNSY)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$2.03-0.49%Close

BUYCRISIS · day 23

[SCORES & PROFILE]

FUND: 7
VALUE: 8
GROWTH: 40
GARP: 7
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-236.5%

REV YoY-

ROE-394.2%

EPS YoY-

ROA-185.9%

GROSS

-628

NET

-621

[VALUATION]

P/E TTM-0.00

P/E FWD-

SECTOR PE22.48

INDUSTRY PE151.48

P/B2.52

P/FCF-

EV/EBITDA-0.52

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.81

ALTMAN Z-

CURR RATIO1.37

ND/EBITDA-

BETA1.39

Cerenome, Inc. (CNSY)

Key stats

Prediction markets

FUNDAMENTALS

Company news